Article information
Full text is only aviable in PDF
Bibliografía
[1.]
A.B. Thompson, D. Daughton, R.A. Robbins, et al.
Intraluminal airway inflammation in chronic bronchitis.
Am Rev Respir Dis, 140 (1989), pp. 1.527-1.537
[2.]
M. Saetía, A. Di Stefano, P. Maestrelli, et al.
Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis.
Am Rev Respir Dis, 147 (1993), pp. 301-306
[3.]
M. Saetta, A. Di Stefano, P. Maestrelli, et al.
Airway eosinophilia in chronic bronchitis during exacerbations.
Am J Respir Crit Care Med, 150 (1994), pp. 1.646-1.652
[4.]
M. Haraguchi, S. Shimura, K. Shirato.
Morphological aspects of airways of patients with pulmonary emphysema followed by bronchial asthma-like attack.
Am J Respir Crit Care Med, 153 (1996), pp. 638-643
[5.]
R. Finkelstein, R.S. Fraser, H. Ghezzo, M.G. Cosio.
Alveolar inflammation and its relation to emphysema in smokers.
Am J Respir Crit Care Med, 152 (1995), pp. 1.666-1.672
[6.]
R. Finkelstein, H.D. Ma, H. Ghezzo, et al.
Morphometry of small airways in smokers and its relationship to emphysema type and hyperresponsiveness.
Am J Respir Crit Care Med, 152 (1995), pp. 267-276
[8.]
C.J. Corrigan, A.B. Kay.
The roles of inflammatory cells in the pathogenesis of asthma and of chronic obstructive pulmonary disease.
Am Rev Respir Dis, 143 (1991), pp. 1.165-1.168
[9.]
American Thoracic Society.
Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 152 (1995), pp. 77-120
[10.]
F.E. Hargreave, G. Ryan, N.C. Thomson, et al.
Bronchial responsiveness to histamine or methacholine in asthma: measurement and clinical significance.
J Allergy Clin Immunol, 68 (1981), pp. 347-355
[11.]
E.F. Juniper, P.A. Frith, F.E. Hargreave.
Airway responsiveness to histamine and methacholine: relationship to minimun teatment to control symptoms of asthma.
Thorax, 36 (1981), pp. 575-579
[12.]
P.J. Brown, H.W. Greville, K.E. Fiucane.
Asthma and irreversible airflow obstruction.
Thorax, 39 (1984), pp. 131-136
[13.]
A.J. Woolcock.
Bronchial hyperreactivity in COPD.
Chest, 85 (1984), pp. 20-23
[14.]
J.O. Morse, M.D. Lebowitz, R.J. Knudson, B. Burrows.
Relation of proteasa inhibitor phenotypes to obstructive lung disease in a community.
N Engl J Med, 296 (1977), pp. 1.190-1.194
[15.]
D.S. Postma, E.R. Bleecker, P.J. Amelung, et al.
Gene susceptibility to asthma: bronchial responsiveness coinhereted with a major gene for atopy.
N Engl J Med, 333 (1995), pp. 894-900
[16.]
T. Matsuse, S. Hayashi, K. Kuwano, et al.
Latent adenoviral infection in the pathogenesis of chronic airways obstruction.
Am Rev Respir Dis, 146 (1992), pp. 177-184
[17.]
N.G.M. Orie, H.J. Sluiter, K. De Vries, et al.
The host factor in bronchitis.
Bronchitis. Assen, pp. 43-59
[18.]
B. Burrows, R.J. Knudson, M.G. Cline, M.D. Lebowitz.
A reexamination of risk factors for ventilatory impairment.
Am Rev Respir Dis, 138 (1988), pp. 829-836
[19.]
D. Postma, M.D. Lebowitz.
Persistence and new onset of asthma and chronic bronchitis evaluated longitudinally in a community population sample of adults.
Arch Intern Med, 155 (1995), pp. 1.393-1.399
[20.]
B. Burrows, F.D. Martínez.
Bronchial responsiveness, atopy, smoking, and chronic obstructive pulmonary disease.
Editorial. Am Rev Respir Dis, 140 (1989), pp. 1.515-1.517
[21.]
F.D. Martínez, G. Antognoni, F. Macri, et al.
Parental smoking enhances bronchial responsiveness in nine -year- old children.
Am Rev Respir Dis, 138 (1988), pp. 518-523
[22.]
A. Sanford, T. Weir, O. Paré.
The genetics of asthma State of the art.
Am J Respir Crit Care Med, 153 (1996), pp. 1.749-1.765
[23.]
A. Pacheco, M. Cuevas, S. Quirce, M. Sánchez-Cano, J. Tamayo, A. Sueiro.
Hypersensivity to Candida albicans in older age patients with COPD.
Eur Respir J, 9 (1996), pp. 88
[24.]
B. Burrows, M. Halonen, R.A. Barbee, et al.
The relationship of serum immunoglobulin E to cigarette smoking.
Am Rev Respir Dis, 124 (1981), pp. 523-525
[25.]
M.D. Lebowitz, D.S. Postma, B. Burrows.
Adverse effects of eosinophilia and smoking on the natural history of newly diagnosed chronic bronchitis.
Chest, 108 (1995), pp. 55-61
[26.]
J.Y. Lacoste, J. Bousquet, P. Chanez, et al.
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis and chronic obstructive pulmonary disease.
J Allergy Clin Immunol, 92 (1993), pp. 537-548
[27.]
G.T. O’ Connor, D. Sparrow, M.R. Segal, S.T. Weiss.
Smoking, atopy, and metacholine airway responsiveness among middie-aged and eiderly men The Normative Aging Study.
Am Rev Respir Dis, 140 (1989), pp. 1.520-1.526
[28.]
D. Postma, H.J. Sluiter.
Prognosis of chronic obstructive pulmonary disease: the Dutch experience.
Am Rev Respir Dis, 140 (1989), pp. 100-105
[29.]
N.R. Anthonisen.
Prognosis in chronic obstructive pulmonary disease: results from multicenter clinical trials.
Am Rev Respir Dis, 140 (1989), pp. 95-99
[30.]
A.J. Woolcock, C.M. Salome, K. Yan.
The shape of the dose-response curve to histamine in asthmatics and normal subjects.
Am Rev Respir Dis, 130 (1984), pp. 71-75
[31.]
J.E. Fish, J.R. Shaver, S.P. Peters.
Airway hyperresponsiveness in asthma It is unique?.
Chest, 107 (1995), pp. 154-156
[32.]
P.D. Paré, C. Amour, S. Taylor, et al.
Airway hyperreactivity in COPD.
Chest, 91 (1987), pp. 40-44
[33.]
E.H. Ramsdale, R.S. Roberts, M.M. Morris, et al.
Differences in responsiveness to hiperventilation and metacholine in asthma and chronic bronchitis.
Thorax, 40 (1985), pp. 422-426
[34.]
E.H. Bel, A.H. Zwinderman, M.C. Timmers, et al.
The protective effect of a beta 2 agonist against excessive airway narrowing in response to bronchoconstrictor stimuli in asthma and chronic obstructive lung disease.
Thorax, 46 (1991), pp. 9-14
[35.]
R. Djukanovic, J.W. Wilson, K.M. Britten.
Mucosal inflammation in asthma.
Am Rev Respir Dis, 142 (1990), pp. 434-457
[36.]
M. Humbert, O. Devergne, J. Cerrina, et al.
Activation of macrophages and cytotoxoc cells during cytomegalovirus pneumonia complicating lung trasplantation.
Am Rev Respir Dis, 145 (1992), pp. 1.178-1.184
[37.]
A.J. Coyle, F. Erard, C. Bertrand, et al.
Virus-specific CD8+ cells can switch to interleukin 5 production and induce airway eosinophilia.
J ExpMed, 181 (1995), pp. 1.229-1.233
[38.]
American Thoracic Society.
Guideliness for the evaluation of impairment/disability in patients with asthma.
Am Rev Respir Dis, 147 (1993), pp. 1.056-1.061
[39.]
M. Saetta, A. DiStefano, P. Maestrelli, et al.
Airway eosinophilia and expression of interleukin 5 protein in asthma and in exacerbations of chronic bronchitis.
Clin Exp Allergy, 26 (1996), pp. 766-774
[40.]
H. Hoshi, I. Ohno, M. Hnma.
IL-5 and GM-CSF inmunostaing of sputum cells in bronchial asthma and chronic bronchitis.
Clin Exp Allergy, 25 (1995), pp. 720-728
[41.]
P.J. Mauser, A.M. Pitman, X. Fernández, et al.
Effects of an antibody to interleukin-5 in a model of asthma.
Am J Respir Crit Care Med, 13 (1995), pp. 360-365
[42.]
A. Janoff, W.A. Pryor, Z.H. Bengali.
Effects of tobáceo smoke components on cellular and biochemical processes in the lung.
Am Rev Respir Dis, 136 (1987), pp. 1.058-1.064
[43.]
C.P. Van Schayck, E. Dompeling, M. Rutten, et al.
The influence of an inhaled steroid on quality of life in patients with asthma or COPD.
Chest, 107 (1995), pp. 1.199-1.205
[44.]
A. Watson, T.K. Lim, H. Joyce, N. Pride.
Failure of inhaled corticosteroids to modify brochoconstrictor or bronchodilator responsiveness in middie-aged smokers with mild airflow obstruction.
Chest, 101 (1992), pp. 350-355
[45.]
H.A.M. Kerstjens, P.L.P. Brand, M.D. Hughes, et al.
A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease.
N Engl J Med, 327 (1992), pp. 1.413-1.419
[46.]
C.P. Van Schayck, E. Dompeling, C.L.A. Van Herwaarden, et al.
Bronchodilator treeatment in modérate asthma or chronic bronchitis: continuous or on demand?. A randomised controlled study.
BMJ, 303 (1991), pp. 1.426-1431
[47.]
P.M. O’Byme, F.E. Hargreave.
Non-invasive monitoring of airway inflammation.
Am J Respir Crit Care Med, 150 (1994), pp. 100-102
[48.]
British Thoracic Society.
Guideliness for management of asthma in adults I Chronic persistent asthma.
Br Med J, 301 (1990), pp. 651-653
Copyright © 1997. Sociedad Española de Neumología y Cirugía Torácica
